295 related articles for article (PubMed ID: 12730862)
1. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease.
Crenn P; Vahedi K; Lavergne-Slove A; Cynober L; Matuchansky C; Messing B
Gastroenterology; 2003 May; 124(5):1210-9. PubMed ID: 12730862
[TBL] [Abstract][Full Text] [Related]
2. [Plasma citrulline as a marker of loss of enterocitary mass in coeliac disease in childhood].
Blasco Alonso J; Serrano Nieto J; Navas López VM; Barco Gálvez A; Vicioso I; Carazo Gallego B; Ortiz Pérez P; Sierra Salinas C
Nutr Hosp; 2011; 26(4):807-13. PubMed ID: 22470028
[TBL] [Abstract][Full Text] [Related]
3. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.
Crenn P; Coudray-Lucas C; Thuillier F; Cynober L; Messing B
Gastroenterology; 2000 Dec; 119(6):1496-505. PubMed ID: 11113071
[TBL] [Abstract][Full Text] [Related]
4. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
Crenn P; Messing B; Cynober L
Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672
[TBL] [Abstract][Full Text] [Related]
5. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
[TBL] [Abstract][Full Text] [Related]
6. Another measurement of the elusive entity called "intestinal function".
Hoffenberg EJ
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):325. PubMed ID: 12968597
[No Abstract] [Full Text] [Related]
7. Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease.
Singh A; Verma AK; Das P; Prakash S; Pramanik R; Nayak B; Datta Gupta S; Sreenivas V; Kumar L; Ahuja V; Makharia GK
J Gastroenterol Hepatol; 2020 Mar; 35(3):438-445. PubMed ID: 31498492
[TBL] [Abstract][Full Text] [Related]
8. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
9. The citrulline generation test: proposal for a new enterocyte function test.
Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
Aliment Pharmacol Ther; 2008 Jun; 27(12):1300-10. PubMed ID: 18331613
[TBL] [Abstract][Full Text] [Related]
10. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
11. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
12. [Whole blood citrulline levels in patients with coeliac disease].
Hozyasz KK; Szaflarska-Popławska A; Ołtarzewski M; Mazur J; Müller L; Jabłońska E; Milanowski A
Pol Merkur Lekarski; 2006 Feb; 20(116):173-5. PubMed ID: 16708633
[TBL] [Abstract][Full Text] [Related]
13. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.
Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E
Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654
[TBL] [Abstract][Full Text] [Related]
14. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population.
Papadia C; Kelly P; Caini S; Corazza GR; Shawa T; Franzè A; Forbes A; Di Sabatino A
Clin Nutr; 2010 Dec; 29(6):795-800. PubMed ID: 20646802
[TBL] [Abstract][Full Text] [Related]
15. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
16. Adult celiac disease with severe or partial villous atrophy: a comparative study.
Malamut G; Matysiak-Budnik T; Grosdider E; Jais JP; Morales E; Damotte D; Caillat-Zucman S; Brousse N; Cerf-Bensussan N; Jian R; Cellier C
Gastroenterol Clin Biol; 2008 Mar; 32(3):236-42. PubMed ID: 18359595
[TBL] [Abstract][Full Text] [Related]
17. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.
Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
Am J Gastroenterol; 2007 Dec; 102(12):2814-9. PubMed ID: 17764491
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune enteropathy and villous atrophy in adults.
Corazza GR; Biagi F; Volta U; Andreani ML; De Franceschi L; Gasbarrini G
Lancet; 1997 Jul; 350(9071):106-9. PubMed ID: 9228963
[TBL] [Abstract][Full Text] [Related]
19. Plasma citrulline levels in paediatric patients with celiac disease and the effect of a gluten-free diet.
Ioannou HP; Fotoulaki M; Pavlitou A; Efstratiou I; Augoustides-Savvopoulou P
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):245-9. PubMed ID: 21233715
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
